News

Alkermes Engages in Insights at Annual Neuropsychiatry Conference

Alkermes Engages in Insights at Annual Neuropsychiatry Conference

Alkermes Set to Take Part in Important Neuropsychiatry Conference

Alkermes plc (Nasdaq: ALKS) has announced its involvement in a major neuroscience event. The TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference this year will serve as a venue to discuss fresh perspectives on mental health treatments.

What Attendees Can Anticipate from the Conference

At the conference, Alkermes' management team will engage in a fireside chat presentation. This event will take place in September, where they’ll discuss advancements in neuropsychiatry and Alkermes’ contributions to enhancing treatment options.

Availability of the Live Webcast

The live presentation is open to the public, accessible through the Investors tab on Alkermes’ official website. This offers a chance for anyone interested to listen in on the valuable insights shared. Additionally, for those who can’t attend live, the webcast will be archived so they can catch up on the discussions later.

About Alkermes plc: A Key Player in Neuroscience

Alkermes plc distinguishes itself as a global biopharmaceutical company focused on creating innovative therapeutic solutions for neurological disorders. Their product lineup includes proprietary treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder. Alongside these, Alkermes is also developing a robust pipeline of clinical and preclinical candidates aimed at addressing specific neurological conditions such as narcolepsy.

Worldwide Presence and Dedication to Innovation

With its headquarters in Ireland, Alkermes boasts a research and development center and corporate office in Massachusetts, as well as a cutting-edge manufacturing facility in Ohio. This arrangement underscores their commitment to innovation, keeping them at the forefront of advancements in neuroscience.

Engaging with Alkermes

Alkermes' dedication to tackling serious neurological issues makes it an essential player in the biopharmaceutical industry. Stakeholders and those interested can connect with the company to learn more about its vision and contributions to neuroscience via their website.

Contact Details

For any inquiries, Alkermes has an Investor Relations team led by Jamie Constantine. Potential investors and other interested parties can reach out directly by calling +1 781 873 2402.

Frequently Asked Questions

What is the TD Cowen 4th Annual Neuropsychiatry Conference?

This conference highlights innovative mechanisms in neuropsychiatry, emphasizing advanced treatment options and research findings in the field.

When is Alkermes taking part in the conference?

Alkermes will participate in the conference in September; specific details about their presentation time will be made available publicly.

How can I view the conference webcast?

The live webcast will be available through Alkermes' official website, located in the Investors tab, and will be offered on-demand for 14 days following the event.

What kinds of treatments does Alkermes offer?

Alkermes develops therapies for conditions such as alcohol and opioid dependence, schizophrenia, bipolar I disorder, and other neurological disorders.

Who should I contact for more information about Alkermes?

If you need further details, you can reach out to Jamie Constantine from the Investor Relations department at Alkermes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Youth Mental Health: New Survey Spurs Action

Updated Category News Views 0

What's the 2025 Survey Telling Us? Numbers hit like a gut punch, don't they? The 2025 National Youth Risk Behavior Survey unveils some hard truths — truths that can't be softer just because we've made headway. We're talking about one in three high schoolers in this country feeling persistently down. That's about 33.3% of them, wrestling with sadness and hopelessness...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 5

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 7

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
Greasezilla Expands Infrastructure with Ashland Facility

Updated Category News Views 3

Greasezilla is shaking up the world of waste management, folks. With municipal sewer systems clogged by fats, oils, and grease, Greasezilla's no-nonsense approach is a breath of fresh air. They've just fired up their new regional hub in Ashland, Virginia, taking another hefty step towards easing this burden on municipalities. This ain't small potatoes—this national...

Continue Reading
Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 2

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading
Riverside Theatre Appoints Seasoned CFO for Growth Phase

Updated Category News Views 6

Change Is Afoot at Riverside Theatre Down in Vero Beach, amid the sun-drenched coziness of Florida’s Treasure Coast, something’s cooking that has nothing to do with sunshine: Riverside Theatre snagged itself a new Chief Financial Officer. As nonprofits go, this one’s not a backyard operation—it’s the largest independent professional theatre in the entire state....

Continue Reading
AdminaHealth's AI Assistant Elevates Billing Solutions

Updated Category News Views 1

AdminaHealth Unveils AI Data Assistant for Enterprises Amid the hustle and bustle of business operations, AdminaHealth has tossed a digital lifeline into the sea of billing chaos. Enter their AI-powered data assistant, now available to the big players on the Enterprise Tier within the AdminaHealth Billing Suite. This tool isn't just some gizmo for show; it's a genuine...

Continue Reading
Class Action Lawsuit Targets Lincoln Educational Services

Updated Category News Views 4

Legal Maneuver Against Lincoln Educational Services Here we go again—another day, another lawsuit. The recent flap with Lincoln Educational Services Corporation (NASDAQ: LINC) is as classic as any market rug pull. Stepping into the spotlight, Wolf Haldenstein Adler Freeman & Herz LLP—a courtroom icon since 1888—has announced a class action lawsuit against Lincoln....

Continue Reading
BlueCollar Backs SuiteWorld 2026 with Platinum Sponsorship

Updated Category News Views 6

BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 0

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading

Top 5 Most Recently Viewed Articles

Core & Main Reports Mixed Q2 Earnings: What Lies Ahead?

Updated Category News Views 68

Core & Main's Q2 Earnings Overview Core & Main (NYSE: CNM) has released its quarterly earnings report, revealing earnings of $0.61 per share. This figure is below the Zacks Consensus Estimate of $0.73 per share and represents a decline from last year's earnings of $0.66 per share. These results have been adjusted to exclude any non-recurring items. With an earnings...

Continue Reading
SI-BONE, Inc. Celebrates Record Q4 Success and 2025 Outlook

Updated Category News Views 222

Impressive Fourth Quarter Achievements of SI-BONE, Inc. SI-BONE, Inc. (NASDAQ: SIBN), a leader in medical devices dedicated to treating sacropelvic disorders, has announced outstanding financial outcomes for the fourth quarter of 2024. The company's innovative strategies and investments have borne fruit, leading to significant growth in revenue and improved performance...

Continue Reading
GAC Vehicles Power Xinhua's World Cup Reporting in Mexico

Updated Category News Views 7

Driving the News: GAC's Role in the World Cup Footie fanatics are in a frenzy as the World Cup unfolds in full gear across North America. In this sea of football fever, the streets of Mexico are teeming with hustling reporters trying to capture every cheer, goal, and intense moment. To meet the hectic demands of Xinhua News Agency's front-line coverage, GAC has stepped...

Continue Reading
Discovering SAIR: A Breakthrough in Protein-Ligand Research

Updated Category News Views 210

SandboxAQ Launches Innovative SAIR Dataset Today marks an exciting development in the realm of drug discovery as SandboxAQ introduces the SAIR (Structurally Augmented IC50 Repository). This substantial dataset comprises an extensive collection of protein-ligand structures annotated with binding affinities, a vital resource for researchers aiming to enhance computational...

Continue Reading
Insight Into WisdomTree's Daily Fund Pricing Activities

Updated Category News Views 167

Understanding WisdomTree's Daily Fund Pricing When it comes to tracking investment performance and pricing, WisdomTree has established itself as a noteworthy player, especially in the realm of exchange-traded funds (ETFs). Regular updates on their fund prices provide vital insights for investors, guiding decisions based on the most recent data. Below is a detailed...

Continue Reading